GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: -0.25 (-1.61%)
Spread: 0.50 (3.333%)
Open: 15.00
High: 15.50
Low: 14.65
Prev. Close: 15.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Angle to raise GBP20 million through shares placing

Thu, 24th Jun 2021 19:30

Angle PLC - Guildford, England-based liquid biopsy company - Launches a placing to raise gross proceeds of up to GBP20 million at a price of 116 pence each. The company says it will issue 17.2 million shares at a price which represents a discount of 6.8% to the closing mid-market price of its shares of 124.50p on Wednesday. finnCap and WG Partners are acting as joint brokers to the company alongside Beech Hill Securities, which is acting as US broker to the company. Angle says it intends to use the proceeds of the placing to progress commercialisation of the Parsortix system.

Current stock price: 125.00p

Year-to-date change: more than doubled from 47.75p on December 31

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2014 08:59

ANGLE Inks Deal With University Medical Center Hamburg-Eppendorf

Read more
4 Aug 2014 08:16

Angle Says Parsortix System Granted Second US Patent

Read more
23 Jul 2014 09:56

ANGLE Makes Further Progress On Parsortix As Losses Widen

Read more
22 Jul 2014 09:59

ANGLE Sees Positive Evaluation Of Parsortix System

Read more
8 Apr 2014 10:43

ANGLE Seeks To Strengthen Parsortix IP With Further Applications

LONDON (Alliance News) - Specialist medical technology company ANGLE PLC said Tuesday that it has taken steps to strengthen its intellectual property covering its Parsortix system. The company has filed claims covering new applications for the Parsortix system, including harvesting blood ce

Read more
17 Mar 2014 10:34

ANGLE Applies For In Vitro Approval For Parsortix In US

LONDON (Alliance News) - ANGLE PLC said Monday it has made a submission to the United States Food and Drug Administration for the authorisation of the sale of its Parsortix cell separation system as an in vitro diagnostic device in the United States. The specialist meditech firm has applied

Read more
24 Feb 2014 10:47

Angle Shares Up On Positive Test Results Using Parsortix

LONDON (Alliance News) - Shares in ANGLE PLC rose 6.7% Monday after it saw positive results using its Parsortix system to analyse Circulating Tumour Cells in the blood of metastatic liver cancer patients. The test, undertaken by Hari Nageswaran at the University of Surrey's Oncology departm

Read more
18 Feb 2014 12:41

UK MIDDAY BRIEFING: Inflation Below Target For First Time In 4 Years

LONDON (Alliance News) - The UK's inflation rate has fallen below the Bank of England's 2% target for the first time in more than four years Tuesday, a decrease that will support governor Mark Carney's recent prediction that the bank's interest rate won't rise for some time to come.

Read more

18 Feb 2014 11:50

UK WINNERS & LOSERS: Randgold, Goldstone Fall As Drilling Results Disappoint

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday. ------- FTSE 100 - WINNERS BHP Billiton, up 1.2%. The Anglo-Australian mining giant has reported an 83% increase in profit for the first half of fiscal

Read more
18 Feb 2014 09:30

ANGLE To Launch Parsortix At Berlin Medical Conference Wednesday

LONDON (Alliance News) - Shares in ANGLE PLC were on the rise Tuesday morning, after the specialist med-tech company said it will launch its Parsortix non-invasive cancer diagnostic system at a science and medical researcher conference in Berlin on Wednesday. ANGLE's pretax loss widened in

Read more
30 Jan 2014 11:28

ANGLE Focused On Market Adoption For Parsortix As Loss Widens

LONDON (Alliance News) - ANGLE PLC said Thursday that it was focused on establishing widespread market adoption for its Parsortix cell separation system following marketing authorisation in Europe, as its pretax loss widened in the half-year ended October 31. Parsortix is a cell separation

Read more
30 Jan 2014 08:33

UK MORNING BRIEFING: BSkyB Up, Diageo Down Amid Lower Open

LONDON (Alliance News) - UK shares have opened lower Thursday, following the decision of the US Federal Reserve to continue tapering its asset purchases.

A large number of UK company reports at the open have seen a positive statement from BSkyB, up 2.4% at the open,

Read more
7 Jan 2014 08:40

ANGLE Appoints Scientific Adviser

Read more
17 Dec 2013 11:53

Angle wins EU authorisation for Parsortix

Medical diagnostic device maker Angle has won European approval for a system used in the diagnosis and treatment of cancer patients. Angle said regulators had authorized its Parsortix cell separation system for use as an in-vitro diagnostic device in the EU. The system uses blood analysis to diagn

Read more
13 Dec 2013 11:41

ANGLE sells Geomerics business to ARM Holdings

Specialist medtech company ANGLE has raised 6.2m pounds after realising its investment in graphics technology developer Geomerics, which it sold to ARM Holdings. The group said the additional financial resources will be used within its Parsortix non-invasive cancer diagnostics business, enabling i

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.